SOS Response Inhibitory Properties by Potential Probiotic Formulations of Bacillus amyloliquefaciens B-1895 and Bacillus subtilis KATMIRA1933 Obtained by Solid-State Fermentation

Curr Microbiol. 2019 Mar;76(3):312-319. doi: 10.1007/s00284-018-01623-2. Epub 2019 Jan 2.

Abstract

The ability of fermentates of two potential probiotic strains, Bacillus amyloliquefaciens B-1895 and Bacillus subtilis KATMIRA1933, to lower the SOS response in bacteria was evaluated using Escherichia coli-based Lux biosensors (pRecA-lux) and the tested bacilli fermentates obtained through solid-state fermentation. The SOS response was stimulated by the addition of ciprofloxacine. Preparations of both Bacillus fermentates demonstrated SOS-inhibitory activity (up to 54.21%). The strain КATMIRA1933 was characterized by higher SOS-inhibitory activity. The active components of the fermentates were stable against heating, proteinase, and RNase action.

MeSH terms

  • Antimutagenic Agents / metabolism
  • Antimutagenic Agents / pharmacology*
  • Bacillus / metabolism
  • Bacillus amyloliquefaciens / metabolism*
  • Bacillus subtilis / metabolism*
  • Biosensing Techniques
  • Ciprofloxacin / toxicity
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Fermentation
  • Probiotics / metabolism
  • Probiotics / pharmacology*
  • SOS Response, Genetics / drug effects*
  • Topoisomerase II Inhibitors / toxicity

Substances

  • Antimutagenic Agents
  • Topoisomerase II Inhibitors
  • Ciprofloxacin